PR-1100

N/A

Report date: 2023/01/07 20:44:13

Base Information

Drug NamePR-1100
Drug Alias NamePR-1100
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulatorsCytokine receptors modulators
TargetsCytokine receptors
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co LtdPrometheus Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdPrometheus Laboratories Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A